Calcium AKG
Asset
Alpha-ketoglutarate metabolite supplementation reducing age-related oxidative stress and supporting cellular metabolism.
- Stage
- Phase 2
- Modality
- Supplement
- Target
- Oxidative stress and ROS signalling
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Brain aging
Phase 2, Not yet recruiting, NCT07861867, clinicaltrials.gov, 7 Oct 2026
Cerebrovascular function
Phase 2, Not yet recruiting, NCT07861867, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors8
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.